“When I joined the Youth Parliament, I was unsure of what to expect, but when we met on Zoom for the first time I realised we had a lot in common: We live with a chronic disease – many of us have done so since childhood - and we felt compelled to become active, share our reality, and communicate about it so that those that can help us change things are aware of the issues affecting our health and quality of life.”

Monica Volini, member of the European Allergy and Asthma Youth Parliament

The European Allergy and Asthma Youth Parliament is a platform for the next generation of leaders in healthcare policy and patient advocacy!

It brings together young allergy and asthma patients and medical professionals between 16-26 years from across Europe. The Youth Parliament is a forum to share experiences and knowledge, to raise awareness for the pressing issues for young patients, and to inform European policymakers on how their work can support young people living with asthma and allergies.

Too often, policy and healthcare fail to recognise the unique needs of young patients who must navigate life with a chronic health condition. This is why the Youth Parliament was formed: so that young patients can bring the youth perspective to the European level, to get familiar with EU policymaking, and to join the network of the next generation of European allergy and asthma patient leaders.

As patient ambassadors, we propose recommendations from a youth perspective on how to improve young patients’ abilities to manage their disease and increase their Quality of Life:

  • Advocate change for all young allergy and asthma patients;
  • Inform European policymakers on our needs and priorities;
  • Propose recommendations from a youth perspective;
  • Improve young patients’ abilities to manage their disease.

Read the European Allergy and Asthma Youth Parliament’s 2022 strategy here.

Read the 2021 strategy here.

For more information, contact This email address is being protected from spambots. You need JavaScript enabled to view it.